Literature DB >> 2546553

Placental estrogen synthetase (aromatase): evidence for phosphatase-dependent inactivation.

F L Bellino1, L Holben.   

Abstract

The acute regulation of estrogen synthetase (aromatase), the cytochrome P450 enzyme system responsible for estrogen production, is not well explored. We report here that aromatase, but not NADPH-cytochrome c (P450) reductase, activity from human term placental microsomes decreased when incubated in phosphate-free buffer at 37 degrees C. Aromatase activity was stabilized by phosphate buffer or by the phosphatase inhibitors tartaric acid or EDTA, but not NaF, in phosphate-free buffer. Alkaline phosphatase also inhibited aromatase in phosphate-free buffer relative to phosphate buffer, but the inactivation appears to be due primarily to proteolytic solubilization of NADPH-cytochrome c reductase from the microsomes by proteases within the alkaline phosphatase preparation. Based on these data, we suggest that the cytochrome P450 component of aromatase may be regulated acutely by phosphorylation-dependent processes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546553     DOI: 10.1016/0006-291x(89)92025-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome.

Authors:  L H Zhang; H Rodriguez; S Ohno; W L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

2.  Phosphorylation of human placental aromatase CYP19A1.

Authors:  Debashis Ghosh; Chinaza Egbuta; Jean E Kanyo; TuKiet T Lam
Journal:  Biochem J       Date:  2019-11-15       Impact factor: 3.857

3.  Relevance of c-Src and protein phosphatase 2A to aromatase activity: Evidence of an acute self-regulating oestrogenic signalling complex in rat central nervous system.

Authors:  Emiliya M Storman; Nai-Jiang Liu; Alan R Gintzler
Journal:  J Neuroendocrinol       Date:  2022-01-18       Impact factor: 3.870

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.